Trials / Terminated
TerminatedNCT00120380
Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)
Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Hannover Medical School · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test whether the addition of inhaled iloprost is safe and effective in patients with idiopathic pulmonary arterial hypertension who are already being treated with the endothelin receptor antagonist bosentan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aerosolized iloprost | |
| DRUG | Placebo |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2006-05-01
- Completion
- 2006-05-01
- First posted
- 2005-07-18
- Last updated
- 2012-08-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00120380. Inclusion in this directory is not an endorsement.